JP2021534097A5 - - Google Patents

Info

Publication number
JP2021534097A5
JP2021534097A5 JP2021506621A JP2021506621A JP2021534097A5 JP 2021534097 A5 JP2021534097 A5 JP 2021534097A5 JP 2021506621 A JP2021506621 A JP 2021506621A JP 2021506621 A JP2021506621 A JP 2021506621A JP 2021534097 A5 JP2021534097 A5 JP 2021534097A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
independently selected
cycloalkyl
alkynyl
Prior art date
Application number
JP2021506621A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021534097A (ja
JP7483678B2 (ja
JPWO2020033488A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/045424 external-priority patent/WO2020033488A1/en
Publication of JP2021534097A publication Critical patent/JP2021534097A/ja
Publication of JP2021534097A5 publication Critical patent/JP2021534097A5/ja
Publication of JPWO2020033488A5 publication Critical patent/JPWO2020033488A5/ja
Application granted granted Critical
Publication of JP7483678B2 publication Critical patent/JP7483678B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021506621A 2018-08-08 2019-08-07 Pad4阻害剤としての置換ベンズイミダゾール Active JP7483678B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862715858P 2018-08-08 2018-08-08
US62/715,858 2018-08-08
PCT/US2019/045424 WO2020033488A1 (en) 2018-08-08 2019-08-07 Substituted benzimidazoles as pad4 inhibitors

Publications (4)

Publication Number Publication Date
JP2021534097A JP2021534097A (ja) 2021-12-09
JP2021534097A5 true JP2021534097A5 (https=) 2022-08-08
JPWO2020033488A5 JPWO2020033488A5 (https=) 2022-08-08
JP7483678B2 JP7483678B2 (ja) 2024-05-15

Family

ID=67766299

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021506621A Active JP7483678B2 (ja) 2018-08-08 2019-08-07 Pad4阻害剤としての置換ベンズイミダゾール

Country Status (18)

Country Link
US (1) US20220402950A1 (https=)
EP (1) EP3833438B1 (https=)
JP (1) JP7483678B2 (https=)
KR (1) KR102825194B1 (https=)
CN (1) CN112805066A (https=)
AU (1) AU2019318415A1 (https=)
BR (1) BR112021002089A2 (https=)
CA (1) CA3108871A1 (https=)
CL (1) CL2021000292A1 (https=)
CO (1) CO2021001219A2 (https=)
EA (1) EA202190464A1 (https=)
ES (1) ES2973714T3 (https=)
IL (1) IL280641A (https=)
MX (1) MX2021001471A (https=)
PE (1) PE20211067A1 (https=)
SG (1) SG11202101176YA (https=)
TW (1) TW202019411A (https=)
WO (1) WO2020033488A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3833671B1 (en) * 2018-08-08 2022-08-24 Bristol-Myers Squibb Company Substituted thienopyrroles as pad4 inhibitors
AU2019319835A1 (en) 2018-08-08 2021-03-25 Bristol-Myers Squibb Company Indole and azaindole inhibitors of PAD enzymes
EP4100405A1 (en) 2020-02-06 2022-12-14 Bristol-Myers Squibb Company Macrocyclic pad4 inhibitors useful as immunosuppressant
TW202140477A (zh) 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑
EP4143189A1 (en) 2020-04-30 2023-03-08 Gilead Sciences, Inc. Macrocyclic inhibitors of peptidylarginine deiminases
TW202241884A (zh) 2020-12-22 2022-11-01 美商基利科學股份有限公司 肽基精胺酸去亞胺酶之抑制劑
WO2022140428A2 (en) 2020-12-22 2022-06-30 Gilead Sciences, Inc. Inhibitors of peptidylarginine deiminases
CN116492462B (zh) * 2023-02-03 2023-09-22 山东第一医科大学附属眼科医院(山东省眼科医院) Pad4抑制剂在防治角膜移植术后免疫排斥反应中的应用
WO2025024265A1 (en) 2023-07-21 2025-01-30 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad4 modulators
WO2026020127A2 (en) 2024-07-19 2026-01-22 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad2 modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS55684B1 (sr) * 2012-07-26 2017-07-31 Glaxo Group Ltd 2-(azaindol-2-il)benzimidazoli kao pad4 inhibitori
US10407407B2 (en) * 2015-05-21 2019-09-10 Glaxosmithkline Intellectual Property Development Limited Benzoimidazole derivatives as PAD4 inhibitors
AR107032A1 (es) 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores bicíclicos de pad4
AR107030A1 (es) * 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores aza-bencimidazol de pad4
KR102398941B1 (ko) * 2016-07-27 2022-05-17 패들락 테라퓨틱스, 인코포레이티드 Pad4의 공유결합성 억제제

Similar Documents

Publication Publication Date Title
JP2021534097A5 (https=)
JP2021534106A5 (https=)
JP2021534108A5 (https=)
JP2021534104A5 (https=)
JP2012505235A5 (https=)
JP2021532109A5 (https=)
JP2016534134A5 (https=)
JP2021531311A5 (https=)
JP2011527686A5 (https=)
JPWO2019195124A5 (https=)
RU2004109812A (ru) Ингибиторы цистеинпротеазы 2-циано-4-аминопиримидинового строения с ингибирующим действием на катепсин к для лечения воспалительных и других заболеваний
JP2013504593A5 (https=)
JP2013544846A5 (https=)
JP2006514006A5 (https=)
RU2010105678A (ru) Гетероциклические амидные соединения как ингибиторы протеинкиназ
JP2005527587A5 (https=)
JP2006509842A5 (https=)
JP2020507589A5 (https=)
JP2023164918A5 (https=)
JP2020531414A5 (https=)
JP2018530582A5 (https=)
JPWO2020033520A5 (https=)
JP2007517900A5 (https=)
JPWO2020033490A5 (https=)
JPWO2020033488A5 (https=)